C

Catalyst Pharmaceuticals
D

CPRX

24.180
USD
0.08
(0.31%)
مغلق
حجم التداول
67,885
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
2,972,021,518
أصول ذات صلة المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).